These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32422446)

  • 21. Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.
    Jackson GL; Edelman D; Weinberger M
    J Gen Intern Med; 2006 Oct; 21(10):1050-6. PubMed ID: 16970554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.
    Kirk JK; Huber KR; Clinch CR
    N C Med J; 2005; 66(6):415-9. PubMed ID: 16438097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
    De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan.
    Yu NC; Su HY; Tsai ST; Lin BJ; Shiu RS; Hsieh YC; Sheu WH
    Diabetes Res Clin Pract; 2009 May; 84(2):194-200. PubMed ID: 19327861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Achievement of cardiovascular goals in patients diagnosed with type 2 diabetes with and without cardiovascular disease].
    Garzón G; Gil Á; Herrero AM; Jiménez F; Cerezo MJ; Domínguez C
    Gac Sanit; 2015; 29(6):425-30. PubMed ID: 26342408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.
    Cambra K; Galbete A; Forga L; Lecea O; Ariz MJ; Moreno-Iribas C; Aizpuru F; Ibañez B
    BMC Fam Pract; 2016 Oct; 17(1):144. PubMed ID: 27729015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trends in the level of control of patients with type 2 diabetes from 2010 to 2015].
    Herrero Gil AM; Pinillos Robles J; Sabio Repiso P; Martín Maldonado JL; Garzón González G; Gil de Miguel Á
    Aten Primaria; 2018 Oct; 50(8):459-466. PubMed ID: 28838742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levels.
    Chiang HH; Tseng FY; Wang CY; Chen CL; Chen YC; See TT; Chen HF
    PLoS One; 2014; 9(10):e109501. PubMed ID: 25347712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008.
    Fhärm E; Cederholm J; Eliasson B; Gudbjörnsdottir S; Rolandsson O
    Diabet Med; 2012 Feb; 29(2):198-206. PubMed ID: 21883434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends of ABC control 2006-2011: a National Survey of Diabetes Health Promotion Institutes in Taiwan.
    Yu NC; Su HY; Chiou ST; Yeh MC; Yeh SW; Tzeng MS; Sheu WH
    Diabetes Res Clin Pract; 2013 Feb; 99(2):112-9. PubMed ID: 23265923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
    Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
    J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016 - The Center for Cardio-metabolic Risk Reduction in South Asia Study.
    Anjana RM; Deepa M; Subashini R; Patel SA; Kondal D; Unnikrishnan R; Tandon N; Prabhakaran D; Narayan KMV; Kadir MM; Mohan V; Ali MK
    Diabet Med; 2021 Feb; 38(2):e14424. PubMed ID: 33067811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
    Fischer LT; Hochfellner DA; Knoll L; Pöttler T; Mader JK; Aberer F
    Cardiovasc Diabetol; 2021 Apr; 20(1):89. PubMed ID: 33894772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.